AZN

AstraZeneca · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Sun 22:02 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About AstraZeneca

AstraZeneca (AZN) is a pharmaceutical company that develops and sells drugs for various conditions such as respiratory,心血管疾病, metabolic, oncology, and neuroscience. It operates within the biopharmaceutical sector.

Ticker	AZN
Name	AstraZeneca
Currency	USD

Reputation

🙂

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral

Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BULLISH

53.32

RSI (14)i

184.53

SMA 20i

171.32

SMA 50i

104.89

SMA 200i

0.00%

1di

0.00%

1wi

1.88%

1mi

3.73%

30d voli

208.45

52w highi

31.59

52w lowi

-10.79%

from highi

2.93

MACDi

Uptrend (50d above 200d)MACD bearish crossover

Computed from 419 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-08 00:18

The stock has been in a consolidation phase with minor fluctuations around the $185-$208 range, indicating that it may be too early to determine if this is a breakout point. The recent price action shows no clear trend beyond minor adjustments, and there are no significant positive or negative news affecting the stock. Given these conditions, further analysis or waiting for more information might be advisable.

qwen2.5:3b

AZN